Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index133
i10-index355
Publications1,361
Citations91,670

Grants

5 total · 4 active

NIH #P01CA275746

Core B: Molecular Pathology and Bioinformatics Core

Active
Amount
$600K–$700K
Period
2024-09-03 → 2029-08-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R25CA233208

MSK Computational Biology Summer Program

Active
Amount
$300K–$400K
Period
2019-07-01 → 2029-06-30
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA273224

Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy

Active
Amount
$700K–$800K
Period
2022-07-01 → 2027-06-30
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

5 total · 4 active

NIH #P01CA275746

Core B: Molecular Pathology and Bioinformatics Core

Active
Amount
$600K–$700K
Period
2024-09-03 → 2029-08-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R25CA233208

MSK Computational Biology Summer Program

Active
Amount
$300K–$400K
Period
2019-07-01 → 2029-06-30
PIs
2

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R01CA273224

Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy

Active
Amount
$700K–$800K
Period
2022-07-01 → 2027-06-30
PIs
3

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #R44HD100243

IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis

Active
Amount
$800K–$900K
Period
2020-07-02 → 2027-05-31
PIs
1

Awarded at PLAKOUS THERAPEUTICS, INC.

NIH #R01CA227534

(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing

Amount
$700K–$800K
Period
2019-04-01 → 2024-03-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Recent Public Signals

  1. New paper: Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer (Clinical Cancer Research)2026-06-26
  2. New preprint: Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers2026-06-22
  3. New NIH award: Core B: Molecular Pathology and Bioinformatics Core2024-09-03

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0003-3882-5000

Professor Insights

Career Trajectory